Daily Judi: Tuesday, October 25, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Fierce Biotech reviews a recent panel discussion on “Artificial Intelligence in Medical Devices” held at the AdvaMed MedTech Conference in Boston this past Monday. Among other aspects, including future regulations and standards, the panelists discussed transparency and patient trust.
Nasdaq examines Pfizer and Moderna's billions of dollars of revenue from their respective coronavirus vaccines, and what future investors should consider.
Meanwhile, a clinical study by Duke University scientists concluded that Ivermectin doesn’t much improve recovery from mild to moderate COVID-19. (CNBC)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
